Stem cell exosome therapy works very well for pulmonary fibrosis, according to a new clinical trial. Patients were administered umbilical cord stem cells intravenously versus a group that received placebo.
For every variable reviewed, such as walking distance, quality of life, and breathing studies, the results were dramatically improved in the stem cell group. Watch R3 Stem Cell CEO David Greene, MD, PhD, MBA explain the outcomes.
R3 Stem Cell offers regenerative therapies with stem cells and exosomes for individuals with COPD and Pulmonary Fibrosis in 80 Centers in 8 Countries. With over 28,000 stem cell procedures in 10 years, R3 is the world's largest provider of regenerative therapies with an 85% patient saftisfaction rate!
R3 has stem cell clinics in Mexico, India, Philippines, USA, Pakistan, UAE, South Africa, Turkey, Europe. Call us today at +1 (844) GET-STEM to set up your free consultation or email info@r3stemcell.com
Comments